title: The influence of ovarian response on gamete intra-Fallopian transfer outcome in older women.
abstract: Fecundity declines with increasing age in women. The pregnancy rate is lower in in-vitro fertilization/embryo transfer (IVF/ET) in women aged greater than or equal to 40 years. We analysed 349 consecutive gamete intra-Fallopian transfer (GIFT) cycles in women aged greater than or equal to 40 years to identify factors which affected the outcome. A maximum of four oocytes were transferred in GIFT as recommended by the Interim Licensing Authority; 61 women (17.5%) had a positive serum beta-human chorionic gonadotrophin, 35 (10%) had a miscarriage and 26 (7.5%) delivered live infants. The pregnancy rate was lower than with younger women while the conception loss was higher. Pregnancy and delivery rates increased as the number of oocytes retrieved increased but declined again if greater than 10 oocytes were retrieved. If 1-3 oocytes were retrieved, the pregnancy rate was 9.7% and the delivery rate was 3.9%; if 4-10 oocytes were retrieved, the pregnancy rate was 22.1% and the delivery rate was 10.1%, and when greater than 10 oocytes were retrieved, the rates were 17.6 and 5.9% respectively. The highest pregnancy rate was when four oocytes were transformed in GIFT (22.4%) and the delivery rate was 10.0%. An adequate response to long down-regulation with gonadotrophin-releasing hormone agonist was also a factor associated with high delivery rates (13.5%). We conclude that the delivery rate after GIFT in women aged greater than or equal to 40 years is low, but there is a subgroup who have an acceptable delivery rate because of a good ovarian response. In this group, pituitary down-regulation improves the outcome of treatment.
authors.affiliation: London Fertility and Gynaecology Centre, UK.
authors.forename: T
authors.initials: T
authors.lastname: al-Shawaf
authors.forename: A
authors.initials: A
authors.lastname: Nolan
authors.forename: R
authors.initials: R
authors.lastname: Guirgis
authors.forename: J
authors.initials: J
authors.lastname: Harper
authors.forename: M
authors.initials: M
authors.lastname: Santis
authors.forename: I
authors.initials: I
authors.lastname: Craft
mesh_terms: D000328:Adult; D000375:Aging / Q000502:physiology*; D002064:Buserelin / Q000627:therapeutic use; D006063:Chorionic Gonadotropin / Q000097:blood; D018997:Chorionic Gonadotropin, beta Subunit, Human; D002996:Clomiphene / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D015181:Gamete Intrafallopian Transfer; D006801:Humans; D008596:Menotropins / Q000627:therapeutic use; D009865:Oocytes / Q000502:physiology; D010053:Ovary / Q000502:physiology*; D010446:Peptide Fragments / Q000097:blood; D011247:Pregnancy; D011256:Pregnancy Outcome
chemical_list: D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human; D010446:Peptide Fragments; D002996:Clomiphene; D008596:Menotropins; D005640:Follicle Stimulating Hormone; D002064:Buserelin